OSUR
OraSure Technologies, Inc. · NASDAQ
- Sector Health Technology
- Industry Medical Specialties
- Website orasure.com
- Employees(FY) 840
- ISIN US68554V1089
Performance
-2.48%
1W
-5.75%
1M
-27.11%
3M
-28.7%
6M
-40.0%
YTD
-9.39%
1Y
Profile
OraSure Technologies, Inc., together with its subsidiaries, provides point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services in the United States, Europe, and internationally. It operates in two segments, Diagnostics and Molecular Solutions. The company's diagnostic products include InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test, OraQuick Ebola rapid antigen test, OraSure oral fluid collection device used in conjunction with screening and confirmatory tests for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D. saliva alcohol test. It also offers genomic products under the Oragene and ORAcollect brands for collecting genetic material from human saliva; Colli-Pee collection devices for the volumetric collection of void urine samples; and microbiome laboratory testing and analytical services. In addition, the company provides microbiome products, such as OMNIgene GUT for self-collecting microbial DNA from feces or stool samples for gut microbiome profiling; OMNIgene GUT DNA and RNA collection devices; and OMNIgeneGUT Dx collection device for collection of human fecal samples and the stabilization of DNA from the bacterial community. Additionally, it provides other diagnostic products, such as immunoassays and other in vitro diagnostic tests. The company markets its products to clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, commercial and industrial entities, disease risk management, diagnostics, pharmaceutical, biotech, nutrition, companion animal, and environmental markets. OraSure Technologies, Inc. was incorporated in 2000 and is based in Bethlehem, Pennsylvania.
Investment Analysis Report: OSUR
Overview
In this investment analysis report, we will delve into a detailed examination of OSUR, a company operating in the Health Technology sector within the Medical Specialties industry. We will analyze various aspects of the company's financial performance, including valuation, financial health, earnings and r...
Technical Analysis of OSUR 2024-05-10
Overview:
In analyzing the technical indicators for OSUR over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days.
Trend Analysis:
- Moving Averages (MA): The 5-day Moving Average (MA) has been declining steadily from ...
Recent News & Updates
- 2024-05-12 22:47
- 2024-05-10 03:04
- 2024-05-09 01:54
- 2024-05-08 20:29
Q1 2024 OraSure Technologies Inc Earnings Call(Yahoo Finance)
- 2024-05-08 15:48
- 2024-05-08 08:57
- 2024-05-08 06:20
- 2024-05-08 05:17
OraSure: Q1 Earnings Snapshot(Yahoo Finance)
- 2024-05-08 04:05
OraSure Reports Q1 '24 Revenue of $54.1 Million(Globenewswire)
- 2024-04-21 20:00
- 2024-04-17 23:30
- 2024-03-28 08:19
- 2024-03-20 20:31
- 2024-03-01 06:33
OraSure Technologies Full Year 2023 Earnings: EPS Beats Expectations(Simply Wall St.)
- 2024-02-28 09:23
Q4 2023 OraSure Technologies Inc Earnings Call(Thomson Reuters StreetEvents)
- 2024-02-28 08:55
- 2024-02-27 17:11
OraSure: Q4 Earnings Snapshot(Associated Press Finance)
- 2024-02-27 16:48
- 2024-02-27 16:05
OraSure Reports Q4 ‘23 Revenue of $75.9 Million(GlobeNewswire)
- 2024-02-27 03:05
OraSure Reports Q4 '23 Revenue of $75.9 Million(Globenewswire)
- 2024-02-13 16:05
- 2024-02-13 03:05
- 2024-02-01 18:42
3 Strong Buy Stocks Under $10: January 2024(InvestorPlace)
- 2024-01-24 08:40
- 2024-01-19 03:45
- 2024-01-18 07:36
- 2024-01-04 07:05
- 2024-01-03 18:05
- 2023-12-22 05:01
- 2023-12-06 06:21
Page 1 of 5
previousnext